1 2 3 4 5 6 7 8 9 10
читать далее ... Banerij М., Sowers J.R. Insulin resistance and cardiovascular disease. //J Clin Endocrinol Metab. - 2001; 86: 713-8 17. Musi N, Hirshman MF, Nygren J. Et all Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes.// Diabetes 2002; 51: 2074-81 18. Nagi D.K., Yudkin J.S. Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups // Diabetes Care. - 1993; 16 (4): 621-9. 19. Najeed S.A., Khan I.A., Molnar J., Somberg J.C. Differential of glyburide (glibenclamidi) and metformin on QT dispersion a potential adenosine triphosptate sensitive K+ channel effect. // Am J Cardiol-2002; 90(10): 1103-6. 20. Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. // Diabetologia.- 1987; 30: 123-31 21. Patane G., Piro S., Rabuazzo A.M., Anello М. et al. Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells // Diabetes. -2001; 49(5): 735-740 17 мс 22. Oiknine R., Mooradian A.D. Drug therapy of diabetes in the elderly // Biomed Pharmacother.-2003; 57(5-6):231 -239. 23. Owen MR, Doran E, Halestrap AP. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex I of the mitochondrial respiratory chain.// Biochem J 2000; 348: 607-14. 24. Rathmann W., Icks A., Haastert B. et al. Undiagnosed diabetes mellitus among patient with prior myocardial infarction.//Z Kardiol 2002; 91: 620-5. 25. Salpeter S.R., Greyber E., Pasternak G.A., Salpeter E.E. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. //Arch Intern Med 2003; 163(21):2594-602. 26. Taubert G., Winkelmann B.R., Schteiffer T. et al. Prevalence, predictors, and conseguences of unrecognized diabetes mellitus in 3266 patients scheduled tor coronary angiography.// Am Heart J 2003; 145:285-91. 27. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complication in overweight patients with type 2 diabetes (UKPDS 34). // Lancet 1998; 352:854-65. 28. Zimmet P.Z., Alberti K.G.M.M. The changing face of macrovascular disease in non-insulin-dependent diabetes mellitus in different cultures: an epidemic inprogress. // Lancet 1997; 350 (suppL1):S1-S4.Источник: Мкртумян А.М., Бирюкова Е.В. Русский медицинский журнал. 2006. Т.14. №27. С.1991-1996